Atlas Trials

Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial

Clinical trial NCT01445821 · TERMINATED

Trial details

NCT number
NCT01445821
Sponsor
Northwestern University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Scleroderma, Systemic
Start date
2011-09-15
Primary completion
2017-01-05
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.